NCT06541847
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06541847
Title A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1 (INSPIRE-NF1)
Acronym INSPIRE-NF1
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Healx Limited
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham RECRUITING Birmingham Alabama 35294 United States Details
Children's Hospital Los Angeles RECRUITING Los Angeles California 90027 United States Details
Children's National Hospital RECRUITING Washington D.C. District of Columbia 20010 United States Details
Ann & Robert H. Lurie Children's Hospital of Chicago RECRUITING Chicago Illinois 60611 United States Details
University of Chicago RECRUITING Chicago Illinois 60637 United States Details
Indiana University RECRUITING Indianapolis Indiana 46202 United States Details
Johns Hopkins Hospital RECRUITING Baltimore Maryland 21287 United States Details
Washington University School of Medicine RECRUITING St Louis Missouri 63110 United States Details
New York University Langone Health RECRUITING New York New York 10016 United States Details
Cincinnati Children's Hospital Medical Center RECRUITING Cincinnati Ohio 45229 United States Details
Children's Hospital of Philadelphia RECRUITING Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field